Level D· Scientific groundwork from lab and animal studiesAnimal StudyPubMedOpen access

Intraoperative Bioprinting for Craniomaxillofacial Bone Reconstruction in Rats and Sheep.

Yeo M., Gupta D., Derman ID., Yildirim S., Singh YP., Gerhard EM.

Animal Study on Face & Skin, published in Small Sci (2025) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
Small Sci (2025)
Country
Germany
Reported sample size
—
Source database
PubMed
PMID
41256203
PMCID
PMC12622550
DOI
10.1002/smsc.202400621
Citations
3

Abstract (original English)

Craniomaxillofacial reconstruction is challenging due to the requirement for diverse manual surgical interventions, which significantly increase as the defect volume enlarges. To address these concerns, we utilized intraoperative bioprinting (IOB) to reconstruct cranial bone defects in surgical settings. We formulated an innovative collagen-based bioink supplemented with human adipose-derived stem cells (hADSCs) or bone morphogenetic protein-2 (BMP-2). The concentration and dispersion state of collagen along with hADSCs were precisely adjusted to enhance cytocompatibility, bioprintability, and osteogenic activities. IOB was first performed via a 3-axis bioprinter on a rat model having a critical-sized calvarial defect (39.3 mm 3 ), which was infilled within ≈30 s and resulted in ≈90% bone coverage area in 8 weeks. Secondly, IOB was conducted on sheep calvarial defects (1,209 mm 3 , ≈31-fold larger compared to the rat defects) using a 6-axis robotic arm, where IOB took ≈5 min per defect. On Week 12, sheep defects treated with IOB revealed accelerated bone repair (≈80% bone coverage area) and mechanical enhancement with 240%, 235%, and 358% increments in Young's modulus, peak force, and energy compared to the non-treated group. The successful execution of IOB in small and large animal models validates the translation potential of IOB for automated surgical interventions.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research